Literature DB >> 7927218

Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.

Q Su1, Y F Liu, J F Zhang, S X Zhang, D F Li, J J Yang.   

Abstract

Expression of insulin-like growth factor II in two human hepatocellular carcinoma cell lines and in hepatitis B, cirrhosis and hepatocellular carcinoma in 419 cases were investigated, and its relationship with the expression of hepatitis B virus X gene was studied by means of immunohistochemical and electron microscopic techniques. The results demonstrated that hepatocellular carcinoma cells (SMMC 7721 and QGY 7703) in culture could express insulin-like growth factor II. Expression seemed to be regulated by cell density, which was suggested as the molecular basis of the contact inhibition of cell proliferation. In tissue sections, cells with high expression of insulin-like growth factor II were observed not only in hepatocellular carcinoma (93%) but also in 95% of the pericancerous liver tissues, 72% of cirrhotic livers, 64% of chronic active hepatitis and 37% of chronic persistent hepatitis. In most cases of hepatocellular carcinoma, insulin-like growth factor II was localized in the cytoplasm of the cancer cells. In the benign liver disorders, four types of cells that highly expressed insulin-like growth factor II were observed: (a) a kind of small liver cell we named the small polygonal liver cell; (b) multinuclear giant hepatocytes; (c) hepatocytes in most of hyperplastic and neoplastic nodules, small hepatocyte nodules and some of regenerative nodules; and (d) some proliferating ductular cells. Even more interestingly, insulin-like growth factor II expression was shown to be closely related to the expression of hepatitis B virus X gene product. We suggest that the activation of insulin-like growth factor II gene and its overexpression may be a crucial step in the processes of hepatitis B virus-associated hepatocarcinogenesis and that the X gene product may activate the insulin-like growth factor II gene through a transactivation mechanism. In addition, we studied the characteristics of small polygonal liver cells, and the roles they may play in the regeneration and carcinogenesis of hepatitis B virus-infected liver are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927218     DOI: 10.1002/hep.1840200404

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis.

Authors:  Z R Fan; D H Yang; J Cui; H R Qin; C C Huang
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice.

Authors:  X Y Cao; J Liu; Z R Lian; M Clayton; J L Hu; M H Zhu; D M Fan; M Feitelson
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver.

Authors:  X Y Cao; J Liu; Z R Lian; M Clayton; J L Hu; M H Zhu; D M Fan; M Feitelson
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.

Authors:  N Lale Satiroglu Tufan; Zhaorui Lian; Jie Liu; Jingbo Pan; Patrick Arbuthnot; Michael Kew; Marcy M Clayton; Minghua Zhu; Mark A Feitelson
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

5.  Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma.

Authors:  Evan J Walker; Stephen A Rosenberg; Jack R Wands; Miran Kim
Journal:  For Immunopathol Dis Therap       Date:  2011

6.  Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.

Authors:  Zhi-Zhen Dong; Deng-Fu Yao; Deng-Bing Yao; Xin-Hua Wu; Wei Wu; Li-Wei Qiu; Dao-Rong Jiang; Jian-Hua Zhu; Xian-Yong Meng
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

Review 7.  The IGF axis and hepatocarcinogenesis.

Authors:  J G Scharf; F Dombrowski; G Ramadori
Journal:  Mol Pathol       Date:  2001-06

8.  Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis.

Authors:  Zheng Wang; You-Bing Ruan; Yang Guan; Sheng-Hong Liu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma.

Authors:  Xiaoming Yao; Ji-Fan Hu; Mark Daniels; Hadas Shiran; Xiangjun Zhou; Huifan Yan; Hongqi Lu; Zhilan Zeng; Qingxue Wang; Tao Li; Andrew R Hoffman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

10.  Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma.

Authors:  I Ariel; H Q Miao; X R Ji; T Schneider; D Roll; N de Groot; A Hochberg; S Ayesh
Journal:  Mol Pathol       Date:  1998-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.